Orikine Bio

Barcelona, Spain

Orikine Bio is a pioneer biotech company in the field of tailored cytokines for the treatment of immune-mediated disorders.

$3.2M raised

Feb 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Orikine Bio raised?

Orikine Bio has raised $3.2M in total funding. The most recent round was Seed. The last funding was announced in February 2026.

Who are Orikine Bio's investors?

Orikine Bio's investors include Asabys Partners, AdBio partners, CDTI Innovación's INNVIERTE program, Ministry of Science and Innovation of Spain.

Where is Orikine Bio headquartered?

Orikine Bio is headquartered in Barcelona, Spain.

What does Orikine Bio do?

Orikine Bio is a pioneer biotech company in the field of tailored cytokines for the treatment of immune-mediated disorders.

What stage is Orikine Bio at?

Orikine Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 2, 2026.

MLA

"Orikine Bio — Funding & Investors." VCBacked, February 2, 2026, https://www.vcbacked.co/company/orikine-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). Orikine Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/orikine-bio

Wikipedia (cite web)

{{cite web |title=Orikine Bio — Funding & Investors |url=https://www.vcbacked.co/company/orikine-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 2, 2026.